Table 1.
Demographic and clinical characteristics of social phobia treatment completers and healthy controls.
| Characteristic | Total | CBT | ACT | Healthy controls |
|---|---|---|---|---|
| Gender (Female) | 47.69% (31/65) | 42.45% (10/22) | 41.67% (10/24) | 57.89% (11/19) |
| Reported race/ethnicitya | ||||
| White | 55.38% (36/65) | 59.09% (13/22) | 54.17% (13/24) | 52.63% (10/19) |
| Hispanic/Latino/a | 12.31% (8/65) | 9.09% (2/22) | 20.83% (5/24) | 5.26% (1/19) |
| Asian–American/Pacific Islander | 21.54% (14/65) | 13.64% (3/22) | 16.67% (4/24) | 36.84% (7/19) |
| Age, in yearsb | 28.07 (6.49) Range: 18–42 |
29.05 (7.18) | 27.68 (5.73) | 27.47 (6.81) |
| Education, in years | 15.26 (1.87) Range: 10–19 |
15.77 (1.97) | 15.04 (1.92) | 14.95 (1.65) |
| Marital status | ||||
| Married/Cohabiting | 10.77% (7/65) | 18.18% (4/22) | 4.17% (1/24) | 10.53% (2/19) |
| Single | 83.08% (54/65) | 77.27% (17/22) | 87.50% (22/24) | 84.21% (16/19) |
| Other | 6.15% (4/65) | 4.55% (1/22) | 8.33% (2/24) | 5.26% (1/19) |
| Children (1+) | 7.69% (5/65) | 9.09% (2/22) | 4.17% (1/24) | 10.53% (2/19) |
| Currently on psychotropic medication | 26.09% (12/46) | 22.73% (5/22) | 29.17% (7/24) | n/a |
| Comorbid anxiety disorder (1+)c | 23.91% (11/46) | 18.18% (4/22) | 29.17% (7/24) | n/a |
| Comorbid depressive disorderc | 13.04% (6/46) | 4.55% (1/22) | 20.83% (5/24) | n/a |
| Social phobia clinical severity rating (mean) | 5.57 (.93) Range: 4–7 |
5.73 (.83) | 5.42 (1.02) | n/a |
a
For race/ethnicity, analyses assessed group differences in minority versus white status.
b
Demographic data was missing for 1 P.
c
Comorbidity was defined as a clinical severity rating of 4 or above on the ADIS.